Why the study?
What factors are associated with increased morbidity and complications in patients treated with dantrolene for anesthetic-induced malignant hyperthermia?
What factors are associated with increased morbidity and complications in patients treated with dantrolene for anesthetic-induced malignant hyperthermia?
Delayed administration of dantrolene and older age increase the risk of complications in malignant hyperthermia, while excessive IV fluids may contribute to pulmonary edema.
No takes yet. Share an insight, caveat, or question.
May warrant faster dantrolene in older MH patients; extends associations but leaves causality and practice change open.
Brandom Bw (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: